Best Grants for HIV / AIDS

About

The Greater New Orleans Foundation is the philanthropic institution dedicated to driving positive impact through philanthropy, leadership, and action in the Greater New Orleans Region.

Our roots extend back to the Community Chest of New Orleans established in 1923. For 100 years, we’ve connected our donors and fundholders with causes that they’re passionate about to affect transformational change. It’s how we help people make the most of their investment, while helping the members of our communities that need it most.

Kahn-Oppenheim Trust (A total of $155,000 Available)

Funding for the development and/or improvement of public health outreach and education programs to inform people about ways to prevent diseases like asthma, diabetes, heart disease, obesity, HIV/AIDS, and others, insofar as these programs involve physical, nutritional, or dietary regimens.

The average grant size is $20,000; grants may be larger or smaller.

The Susan Terry Foundation Grant Program

Empowering Communities, One Grant at a Time

The Susan Terry Foundation Proudly supports local opportunities and initiatives through community-focused grants in Tampa Bay and Sarasota.

The Susan Terry Foundation is committed to strengthening communities by supporting innovative, impactful projects that serve the public good. Through our grant program, we provide funding to individuals, organizations, and research teams working on non-event initiatives that align with our mission of community enrichment and positive change.

We invite applicants with clearly defined goals, thoughtful planning, and a strong commitment to making a difference. Whether you’re launching a new program, conducting meaningful research, or developing a long-term community initiative, we encourage you to apply. This program does not fund event sponsorships or promotional activities.

The SCORCH Program: Phase 2 aims to enhance the understanding of single cell biology in the context of HIV and Substance Use Disorder (SUD). Building on previous research, this initiative will explore new single cell approaches to investigate the interactions between SUD and HIV progression at various biological levels. By leveraging advanced techniques, the program seeks to identify candidate mechanisms and potential therapeutic targets, ultimately contributing to innovative solutions for SUDs and HIV-related challenges.

About Patient Advocate Foundation

Patient Advocate Foundation is the nation’s most comprehensive nonprofit dedicated to helping patients navigate, access, and afford the care they need—while improving the healthcare system for all.

Who we are and our impact

Patient Advocate Foundation provides financial assistance to help patients afford treatment and cost of living needs, personalized case management to navigate complex healthcare and social needs challenges, and a wide array of resources to empower people to take charge of their health. Since our founding in 1996—and joining forces with the PAN Foundation in 2026—we have helped 3.8 million patients navigate and access care, granted over $7 billion in financial assistance, served 350,000 people through personalized case management and elevated the patient’s voice to drive improvements in the healthcare system.

HIV, AIDS, and prevention

Help with healthcare costs for HIV, AIDS, and prevention

This TotalAssist fund helps you pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, and other expenses.

About the disease

HIV, also known as human immunodeficiency virus or acquired immunodeficiency syndrome, is a virus that attacks the immune system. When left untreated, it can develop into AIDS. HIV is a chronic disease that affects the immune system.

Gilead Sciences

At Gilead, we are relentlessly committed to advancing transformative therapies for the most serious diseases, delivering an exponentially positive impact on health.

For more than three decades, we have combined scientific rigor with a deep sense of purpose to improve health outcomes and reimagine care. Our work spans more than 35 countries with a focus on three therapeutic areas: virology, oncology, and inflammation, where unmet medical needs remain greatest.

From individual patients to whole populations, we’re committed to delivering healthier futures for people and communities worldwide.

Our Mission: To discover, develop and deliver innovative therapeutics for people with life-threatening diseases.

HIV Prevention NOVA 2026

Program Description

Gilead Sciences invites research proposals that advance the evidence base for innovative and scalable models of delivery for long-acting (LA) HIV pre-exposure prophylaxis (PrEP) in the United States.

This Topic of Interest (TOI) is focused on care delivery models implemented in non-traditional settings, defined as clinical and non-clinical environments where PrEP services are not routinely provided. Emphasis is placed on approaches that reflect real-life practice and address gaps in current PrEP delivery infrastructure.

Persistent inequities in PrEP uptake in the U.S. suggest that expanding availability within traditional clinical settings alone is unlikely to reach all populations with unmet PrEP need.1,2 Rigorous implementation studies in non-traditional settings where PrEP services are not routinely provided are needed to evaluate whether these models can reduce access barriers and improve equitable reach among individuals who may benefit from PrEP.2,3,4

The goal of this TOI is to generate practical, decision-relevant evidence that informs how LA PrEP can be implemented, scaled, and sustained in real-life U.S. settings.

The Ryan White HIV/AIDS Program Part B AIDS Drug Assistance Program Training and Technical Assistance aims to enhance the capacity of ADAPs. By providing essential tools and expert guidance, the program seeks to improve health outcomes for individuals living with HIV in an evolving healthcare landscape. This initiative is funded by the US HHS through the Health Resources & Services Administration, ensuring support and resources are effectively allocated to meet the needs of vulnerable populations.

The Ryan White HIV/AIDS Program Part D provides supplemental funding aimed at enhancing the infrastructure and capacity of organizations to deliver high-quality, family-centered HIV care services. This initiative focuses on two key areas: HIV Care Innovation and Infrastructure Development, ensuring improved access to essential services for women, infants, children, and youth affected by HIV.

This project aims to enhance health outcomes for women living with HIV in the South by integrating HIV care with comprehensive women's health services through coordinated Clinic and Community Collaboratives. By funding organizations to implement targeted strategies such as culturally responsive services and learning collaboratives, the initiative seeks to improve access to essential health services, increase the number of women initiating rapid ART, and foster sustainable healthcare models that address the unique needs of this population.

This funding opportunity aims to enhance a web-based ordering portal for distributing 1.5 million HIV and STI self-tests to high-burden communities. By optimizing access to these self-tests, the initiative seeks to raise awareness, prevent new infections, and improve the health outcomes of users, thereby contributing to better overall public health and wellbeing.

The HIV Care Grant Program aims to enhance access to comprehensive, high-quality HIV care and treatment for low-income individuals in Pacific Island territories. Funded by the US HHS: Health Resources & Services Administration (HRSA), this initiative supports states and territories in developing effective systems of care, ensuring that those affected by HIV receive the necessary treatment and support to improve health outcomes.

The Ryan White HIV/AIDS Program Part B Supplemental Grant aims to provide essential funding to support HIV care and treatment services across states and territories. This program supplements existing formula-based funding from the RWHAP Part B and ADAP, improving access to necessary resources for those affected by HIV/AIDS. By enhancing support structures, it addresses critical healthcare needs, ensuring better health outcomes for vulnerable populations.

The HIV Care Grant Program, funded by the US HHS: Health Resources & Services Administration (HRSA), aims to enhance access to high-quality HIV care and treatment for low-income individuals. This initiative supports states and territories in developing comprehensive systems to address the needs of those living with HIV. By providing essential resources, the program seeks to improve health outcomes and ensure that vulnerable populations receive the necessary support and services.

The Ryan White HIV/AIDS Program Part C Capacity Development Program aims to enhance the capabilities of community-based organizations, focusing on improving health outcomes and decreasing HIV transmission. This initiative supports individuals who have not yet accessed regular HIV care, emphasizing innovative care solutions and infrastructure development to address these critical needs.

The AIDS Drug Assistance Program (ADAP) Emergency Relief Funds aim to provide essential funding to states and territories. This initiative focuses on preventing, reducing, or eliminating waiting lists for ADAP services, ensuring timely access to necessary medications and support for individuals living with HIV/AIDS. This program addresses critical funding shortfalls, enhancing the healthcare infrastructure and improving health outcomes in affected communities.

The Ryan White HIV/AIDS Program (RWHAP) Integrated HIV/AIDS Planning Resource Allocation Cooperative Agreement aims to enhance the effectiveness of HIV prevention and care planning for RWHAP Parts A and B recipients. Through the provision of training, tools, and technical assistance, this initiative seeks to optimize resource allocation and strengthen the overall system of HIV care and treatment, ultimately improving health outcomes for those affected by HIV.

DC Health

The mission of DC Health is to promote and protect the health, safety, and quality of life of  residents, visitors, and those doing business in the District of Columbia. The agency is  responsible for identifying health risks; educating the public; preventing and controlling diseases,  injuries, and exposure to environmental hazards; promoting effective community collaborations;  and optimizing equitable access to community resources.

HAHSTA Prevention Services

Purpose

This funding announcement is to support a comprehensive approach that identifies and prevents HIV, STI, and HBV/HCV among populations, such African American women, youth (18-24), men who engage in male to male sexual contact (MMSC), biological males who identify as female, biological females who identify as male, African American males, unhoused individuals, and others most at risk for exposure. Applicants should ensure that all people are aware of their health status and of methods to reduce their risk of these diseases. This approach may lead to improved health outcomes, enhanced self-efficacy, improved health literacy, viral suppression, and reduced new infections. The framework fully supports the Ending the HIV Epidemic (EHE) in the District of Columbia (DC).

Applicants who exhibit the capacity to deliver comprehensive HIV prevention activities that include HIV, STI, and HBV/HCV screening and delivery of PrEP/PEP education will be considered for funding. Services are to be fully accessible and well-suited to each population’s behavioral and cultural settings.

The National Institute of Mental Health is inviting research applications for the AIDS Research Center program, which includes Developmental Centers and full Research Centers. This initiative aims to enhance interdisciplinary HIV/AIDS research through collaboration and innovative approaches across various scientific domains. The program emphasizes alignment with national strategies and encourages applications from teams skilled in fostering partnerships with diverse stakeholders. Although applications are currently not being solicited, this notice allows potential applicants time to prepare strong proposals.

The Texas HIV Medication Program (THMP) provides medications approved by the Food and Drug Administration (FDA) and insurance assistance for the treatment of HIV and its related complications for low-income Texans. To qualify for medications, potential clients who meet eligibility criteria must complete an application for assistance. Once approved, a client receives medications at an assigned pharmacy in their community.

Florida’s Housing Opportunities for Persons with AIDS Program is a federal program designed to directly address the housing needs and supportive services of individuals living with HIV/AIDS and their families. In addition, the project sponsors will be responsible for administrative oversight of all housing and supportive services funded through these contracts.

The Housing Opportunities for Persons with AIDS (HOPWA) program, administered by the Indiana Housing and Community Development Authority (IHCDA), provides crucial housing funding to non-profit organizations assisting individuals and families affected by AIDS/HIV. Available in 77 counties across Indiana, it prioritizes agencies dedicated to supporting these vulnerable populations, ensuring they receive the necessary resources and support to thrive in their communities.

SSUS State Opioid Grant shall be used to fund direct services for Core Harm Reduction, Harm Reduction Health, Overdose Prevention & Response Innovation, and planning activities for Capital Improvements to clients with behaviors that make them vulnerable to HIV/STD transmission as a result of injection drug use and support harm reduction and overdose prevention services at syringe access locations, harm reduction centers and county health departments.  This opportunity is limited to entities who were funded under DHSTS Opioid 2026 & DHSTS Opioid Expansion 2026. 

To support the development and implementation of Comprehensive Status - Neutral HIV Services for Focus Populations most attended by HIV. Programs must provide impactful and innovative services, either with specific stages or along the full continuum of HIV testing, prevention, and care/treatment. Programs must provide engagement and linkage to an intentional and exceptional intervention, but re-imagined ensuring services are customer-centered , culturally aware and trauma-informed. 

The Father's Table Foundation Grant aims to glorify God by addressing the immediate and future needs of women and children globally. This selective grant process emphasizes building self-sufficiency and resilience among beneficiaries, focusing on proven partners capable of expanding their impact. The foundation supports a diverse range of projects, including employment assistance, education, humanitarian aid, and health care, ensuring that aid not only meets urgent needs but also fosters long-term sustainability.

The Alphawood Foundation, a private grant-making organization based in Chicago, focuses on supporting initiatives that promote equity, justice, and human rights. They award grants to non-profits in areas such as arts education, LGBTQ+ health and rights, and community empowerment, particularly for marginalized groups. Their funding emphasizes unrestricted operational support, prioritizing organizations aligned with their mission and that primarily serve the Chicago metropolitan area and Northwest Indiana.

The Gamma Mu Foundation, established in 1988, aims to support the LGBT community in rural and underserved areas through various grants. Initially focused on HIV/AIDS projects, it now funds scholarships and services for diverse LGBT subpopulations. With over $2 million awarded, the Foundation prioritizes initiatives that enhance community support, public education, and health programs. It emphasizes projects that build organizational capacity and provide essential services where resources are limited, ensuring ongoing support for vital health and social services.

The Global D-Prize Competition aims to alleviate extreme poverty by seeding social impact organizations in low-and-middle income countries. With grants of up to $20,000, it supports entrepreneurs launching new ventures. Applicants are encouraged to distribute existing, evidence-based poverty interventions. The competition targets areas such as health, education, and livelihoods, fostering innovative solutions. D-Prize seeks to make high-impact products universally accessible and believes that social enterprises can effectively address pressing needs in communities.

The Mérieux Foundation Small Grants Program aims to enhance the living conditions of vulnerable populations by improving access to diagnostics and healthcare in developing countries. The program supports local organizations dedicated to combat infectious diseases affecting mothers and children, including HIV/AIDS and malaria. By fostering partnerships and providing training, the foundation strengthens health systems while promoting research and public health initiatives. Projects must align with the foundation's mission and demonstrate tangible benefits for target populations.